UK Chancellor Rachel Reeves Seeks to Retain Post Amid Labour Leadership Shift Tax Season 2025 New Wrinkles for Online Sellers and EV Owners May Offer Savings Goldman Sachs Sees Limited Impact From Latest US Sanctions on Russian Oil Exports Disneys The Mandalorian and Grogu Opens to 82 Million Marking a Low Point for Star Wars Franchise Russias Yolka Drone Interceptor Operational Constraints and Defense Sector Implications RubioModi Meeting Puts US Energy Exports to India in Focus Amid Iran Tensions Mesa Laboratories Inc MLAB Q1 2026 Earnings Stellar EPS Surprise of 130 Drives Optimism Amidst Quiet Revenue Period KALU Q1 2026 Earnings Massive EPS Surprise Highlights Operational Strength Peraso Inc PRSO Q1 2026 Earnings Narrower Revenue Disclosure as EPS Misses Estimates PRVA Q1 2026 Earnings Profit Miss Overshadowed by Slight Stock Gain AGYS Q1 2026 Earnings Strong EPS Beat Despite Modest Stock Decline Invesco Q1 2026 Earnings EPS Misses Estimates Despite Modest Stock Gain TKO Group Holdings TKO Rallies 586 Testing Key Resistance Zone Bold Eagle Acquisition Corp Right BEAGR Drops 25 to 021 Nearing Critical Support Wetour Robotics WETO Sheds Nearly 9 Testing Key Support Amid Heightened Selling Pressure SoundThinking SSTI Edges Higher Amid Consolidation Testing Key Resistance Zone Lazard Global Total Return and Income Fund LGI Sees Modest Uptick Amid RangeBound Trading SEC Postpones Decision on Tokenized Stock Exemption Crypto Market Reacts VTEX Q1 2026 Earnings EPS Misses Estimates Stock Slides on Disappointing Profitability Gyrodyne LLC GYRO Holds Steady at 711 as Support and Resistance Levels Define Trading Range Capgemini Outlines Strategic Plan to Capture AI Growth Opportunities Through 2028 Summer Electric Bills Surge as Rising Temperatures and Power Costs Raise Concerns Julius Baer Reports SFr 528 Billion AUM Expects Substantially Higher FirstHalf Profit Hardide Secures 24 Million Order from North American Energy Client US Equity Funds See Outflows as Investors Eye Higher Bond Yields EU Fines Temu 200 Million for Failing to Curb Sale of Illegal and Unsafe Products URA Leverages Medtech Partnerships as It Prepares for IPO